Transplantation of the Spleen
- 1 September 2007
- journal article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 246 (3) , 436-446
Abstract
To describe the effect of the splenic allograft in human multivisceral transplantation. We performed transplants of the spleen as part of a multivisceral graft in an attempt to decrease both the risk of infection from an asplenic state and the risk of rejection by a possible tolerogenic effect. To our knowledge, this is the first report of human splenic transplantation in a large series. All primary multivisceral recipients who received a donor spleen (N = 60) were compared with those who did not receive a spleen (N = 81). Thirty-five of 60 (58%) are alive in the spleen group, and 39 of 81 (48%) are alive in control group (P = 0.98). In univariate analysis, splenic recipients showed superiority in freedom-from-any rejection (P = 0.02) and freedom-from-moderate or severe rejection (P = 0.007). No significant differences were observed in analyses of infectious complications between the spleen and control groups. Both platelet and leukocyte counts became normal in splenic patients, whereas these counts were significantly increased in nonsplenic recipients. Observed incidence of graft versus host disease (GVHD) was 8.25% (5 of 60) in the spleen group and 6.2% (5 of 81) in the control group (P = 0.70). Increased incidence of autoimmune hemolysis was observed in the spleen group. Allograft spleen can be transplanted within a multivisceral graft without significantly increasing the risk of GVHD. The allogenic spleen seems to show a protective effect on small bowel rejection. Further investigation with longitudinal follow-up is required to precisely determine the immunologic and hematologic effects of the allograft spleen.Keywords
This publication has 37 references indexed in Scilit:
- Severe cold agglutinin disease caused by recurrent monomorphic Epstein–Barr virus (EBV)‐associated post‐transplant lymphoproliferative disorder (PTLD), clonally related to an EBV‐negative plasmacytic hyperplasia in a pediatric multivisceral organ transplant recipientPediatric Transplantation, 2007
- Intestinal and Multivisceral Transplantation in ChildrenAnnals of Surgery, 2006
- Immunologic Benefits of Spleen Transplantation in the Absence of Graft-Versus-Host DiseaseAnnals of Surgery, 2006
- 100 Multivisceral Transplants at a Single CenterAnnals of Surgery, 2005
- Severe hemolytic anemia due to passenger lymphocytes after living‐related bowel transplantClinical Transplantation, 2004
- Can spleen transplantation induce tolerance? A review of the literatureTransplant International, 2003
- Human marginal-zone B cellsImmunology Today, 1998
- The Role Of The Spleen In Pancreas TrnsplantaionTransplantation, 1993
- INDUCTION OF TRANSPLANTATION TOLERANCE IN RATS BY SPLEEN ALLOGRAFTS III. THE ROLE OF T SUPPRESSOR CELLS IN THE INDUCTION OF SPECIFIC UNRESPONSIVENESSTransplantation, 1987
- SPLENIC TRANSPLANTATION IN A CASE OF GAUCHER'S DISEASEThe Lancet, 1971